FilingReader Intelligence

Haohai Biotec shareholder faces regulatory investigation

May 7, 2025 at 05:04 PM UTCBy FilingReader AI

Shanghai Haohai Biological Technology Co., Ltd. (HKEX: 6826) announced that controlling shareholder Jiang Wei is being investigated by the CSRC for suspected insider trading, as detailed in Notice No.: Zheng Jian Li An Zi 0382025016. The company stated the investigation relates to Mr. Jiang personally and will not materially impact the daily operation of the company. Haohai Biotec assures investors it will continue to comply with disclosure obligations and cooperate with the investigation.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Shanghai Haohai Biological Technology publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →